Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
GSK1278863 in Japanese Hemodialysis Patients with Anemia
NCT02829320Phase 3Completed
- Sponsor
- GSK
- Start
- Aug 2016
- Primary completion
- May 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of daprodustat in anemia of chronic kidney disease (CKD-A), sponsored by GSK. Started Aug 2016; status: completed.
02
Drugs
daprodustat
03
Conditions
anemia of chronic kidney disease (CKD-A)
Beyond the preview
Go deeper on NCT02829320.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02829320.